UPDATE : Thursday, October 17, 2019
상단여백
FDA OKs AbbVie’s Hepatitis C drug to shorten treatment duration by Lee Han-soo 2019-10-08 18:04
Severance Hospital develops AI-platform detecting gastric cancer with high accuracy by Lee Han-soo 2019-10-08 16:06
Allergan Korea to replace breast implant without time limit by Lee Hye-seon 2019-10-08 15:22
Korea, Peru compare notes on telemedicine by Lee Han-soo 2019-10-08 15:20
Most of weight loss drug Saxenda irregularly distributed by Kwak Sung-sun 2019-10-08 15:19
라인
Medtronic Korea denies regulatory negligence over recalled insulin pumps by Kim Yun-mi 2019-10-08 15:05
Propofol abuse, addiction increasing at alarming rate by Lee Han-soo 2019-10-07 17:56
Yuyang DNU, NSCI to develop treatment for dry macular degeneration by Lee Han-soo 2019-10-07 16:54
Civic group protests regulator’s inaction over insulin pumps FDA recalled by Lee Hye-seon 2019-10-07 16:10
‘Kosdaq firms listed for exceptional tech need special monitoring’ by Jeong Sae-im 2019-10-07 15:51
라인
Regulator remains unclear on who got Allergan's breast implant by Lee Han-soo 2019-10-07 14:58
Sanofi confirms prolonged PFS in patients with advanced gastric cancer by Lee Han-soo 2019-10-07 14:39
Galderma Korea workers feel insecure after separation from Nestle by Kim Yun-mi 2019-10-07 14:38
SK Plasma launches human immunoglobulin in Brazil by Lee Han-soo 2019-10-07 11:23
Albis most prescribed ranitidine drug with carcinogen risk by Kwak Sung-sun 2019-10-07 11:23
라인
Qurient sets up joint firm with Nobel chemistry prize winner by Lee Han-soo 2019-10-04 17:45
Lilly's Verzenio extends life for women with advanced breast cancer by Lee Han-soo 2019-10-04 16:15
‘New law to support advanced biopharmaceuticals, ensure safety’ by Lee Hye-seon 2019-10-04 15:18
Regulator under fire for neglecting reported side effects of Invossa by Lee Han-soo 2019-10-04 14:59
Severance confirms efficacy, safety of Yuhan's lung cancer drug Lazertinib by Lee Han-soo 2019-10-04 14:39
여백
여백
여백
Back to Top